Then, the mean weight loss was determined and statistically analyzed.
The study had to have presented the outcome (O) of mean weight loss from study initiation to study completion.
Mean weight loss from baseline was 7.3 and 6.1 kg for the PMR and control groups (P<0.07), respectively.
At 1 year participants had maintained a mean weight loss of 5.5% (SD = 10.1) of initial body weight.
To determine the mean weight loss (MWL) of newborns and to examine the effect of weight loss > 7% on exclusive breastfeeding rates.
The mean weight loss among more than 5,000 men and women in the National Weight Control Registry is 60 pounds, and the group has maintained that loss for roughly five years.
After 12 weeks of energy restriction and 4 weeks of energy balance, the mean weight loss was 8.5±0.6 kg, but the decrease in weight was not affected by the diet composition (SP −9.1±0.7%, HP −8.7±0.7%; P=0.44).
The mean weight loss of the treatment group was 3.60+/-0.64 lbs.
Despite feeding tube placement in 35 patients (85%), the mean weight loss during chemoradiotherapy was 13.3% of initial body weight.
Experiment was carried out in triplicates and mean weight loss was calculated.
CONCLUSIONS Among overweight and obese adults, the use of SBWI resulted in a greater mean weight loss than STEP over 18 months.
